Bulletin
Investor Alert

Nov. 1, 2018, 3:12 a.m. EDT

Smith & Nephew revenue up, backs outlook

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By Carlo Martuscelli

Smith & Nephew PLC (SN.LN) said Thursday that revenue in the third quarter rose 2% and backed its full-year guidance.

The company said revenue for the quarter ended Sept. 29 was $1.17 billion, and rose 3% on an underlying basis compared with the previous year.

It attributed the underlying growth to its performance in the U.S. and emerging markets.

The advanced wound bioactives division continued to decline, although growth in reconstruction, sports-medicine joint repair and advanced wound devices was strong, the FTSE-100 listed medical-equipment manufacturer said.

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.